Bromocriptine monotherapy overcomes prostate cancer chemoresistance in preclinical models.
Bai L, Li X, Yang Y, Zhao R, White EZ, Danaher A, Bowen NJ, Hinton CV, Cook N, Li D, Wu AY, Qui M, Du Y, Fu H, Kucuk O, Wu D.
Bai L, et al. Among authors: zhao r.
Transl Oncol. 2023 Aug;34:101707. doi: 10.1016/j.tranon.2023.101707. Epub 2023 Jun 2.
Transl Oncol. 2023.
PMID: 37271121
Free PMC article.